DK0646596T3 - Nucleinsyre-bindende oligomerer med C-forgrening til terapi og diagnostik - Google Patents

Nucleinsyre-bindende oligomerer med C-forgrening til terapi og diagnostik

Info

Publication number
DK0646596T3
DK0646596T3 DK94113573T DK94113573T DK0646596T3 DK 0646596 T3 DK0646596 T3 DK 0646596T3 DK 94113573 T DK94113573 T DK 94113573T DK 94113573 T DK94113573 T DK 94113573T DK 0646596 T3 DK0646596 T3 DK 0646596T3
Authority
DK
Denmark
Prior art keywords
branching
nucleic acid
diagnostics
therapy
binding oligomers
Prior art date
Application number
DK94113573T
Other languages
English (en)
Inventor
Dr Antonius Loebberding
Dr Burkhard Mielke
Dr Christoph Schwemler
Dr Eckhard Schwenner
Dr Udo Stropp
Dr Wolfgang Springer
Dr Axel Kretschmer
Dr Thorsten Poetter
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Application granted granted Critical
Publication of DK0646596T3 publication Critical patent/DK0646596T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/63—Esters of sulfonic acids
    • C07C309/64—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms
    • C07C309/65—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms of a saturated carbon skeleton
    • C07C309/66—Methanesulfonates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • C07K14/003—Peptide-nucleic acids (PNAs)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
DK94113573T 1993-09-13 1994-08-31 Nucleinsyre-bindende oligomerer med C-forgrening til terapi og diagnostik DK0646596T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4331011A DE4331011A1 (de) 1993-09-13 1993-09-13 Nukleinsäuren-bindende Oligomere mit C-Verzweigung für Therapie und Diagnostik

Publications (1)

Publication Number Publication Date
DK0646596T3 true DK0646596T3 (da) 1999-11-29

Family

ID=6497575

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94113573T DK0646596T3 (da) 1993-09-13 1994-08-31 Nucleinsyre-bindende oligomerer med C-forgrening til terapi og diagnostik

Country Status (11)

Country Link
US (1) US5849893A (da)
EP (1) EP0646596B1 (da)
JP (1) JPH07112969A (da)
AT (1) ATE180494T1 (da)
AU (1) AU7161994A (da)
CA (1) CA2131760A1 (da)
DE (2) DE4331011A1 (da)
DK (1) DK0646596T3 (da)
ES (1) ES2131612T3 (da)
GR (1) GR3030708T3 (da)
SI (1) SI0646596T1 (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7825215B1 (en) * 1993-04-26 2010-11-02 Peter E. Nielsen Substituted nucleic acid mimics
DE4331012A1 (de) * 1993-09-13 1995-03-16 Bayer Ag Nukleinsäuren-bindende Oligomere mit N-Verzweigung für Therapie und Diagnostik
US6133444A (en) * 1993-12-22 2000-10-17 Perseptive Biosystems, Inc. Synthons for the synthesis and deprotection of peptide nucleic acids under mild conditions
US5539083A (en) * 1994-02-23 1996-07-23 Isis Pharmaceuticals, Inc. Peptide nucleic acid combinatorial libraries and improved methods of synthesis
AU4159396A (en) * 1994-11-14 1996-06-06 Chiron Corporation Synthesis of peptide nucleic acids (pnas) and analogues via submonomer approach
EP0840741B1 (en) * 1995-06-07 2004-04-28 Perseptive Biosystems, Inc. Pna-dna chimeras and pna synthons for their preparation
GB9621367D0 (en) 1996-10-14 1996-12-04 Isis Innovation Chiral peptide nucleic acids
US6054568A (en) * 1998-01-16 2000-04-25 The Perkin-Elmer Corporation Nucleobase oligomers
US6030997A (en) * 1998-01-21 2000-02-29 Eilat; Eran Acid labile prodrugs
HUP0203338A2 (hu) * 1999-04-13 2003-03-28 Abbott Gmbh & Co. Kg Integrin receptor ligandumok
HUP9902217A3 (en) * 1999-06-29 2002-07-29 Szegoe Peter Polycation based bioconjugates and process for producing thereof
US6716961B2 (en) 2001-10-30 2004-04-06 Isis Innovation Limited Chiral peptide nucleic acids with a N-aminoethyl-d-proline backbone
DK1513871T3 (da) * 2002-02-04 2009-02-23 Isis Innovation Pyrrolidinyl peptid nucleinsyrer
ATE449103T1 (de) * 2002-09-08 2009-12-15 Applera Corp Festphasengebundene pna-dimere und deren synthese
WO2008070525A1 (en) * 2006-12-04 2008-06-12 Luminex Corporation Oxocarbonamide peptide nucleic acids and methods of using same
CN105555756B (zh) 2013-06-28 2018-12-07 奥克兰联合服务有限公司 氨基酸缀合物和肽缀合物及缀合方法
AU2015370479B2 (en) 2014-12-23 2020-07-23 Auckland Uniservices Limited Amino acid and peptide conjugates and uses thereof
JP7161404B2 (ja) 2016-02-26 2022-10-26 オークランド ユニサービシーズ リミティド アミノ酸及びペプチド接合体及び接合方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3650349T2 (de) * 1985-03-15 1995-12-14 Antivirals Inc Immunotestmittel für polynukleotid und verfahren.
US4994368A (en) * 1987-07-23 1991-02-19 Syntex (U.S.A.) Inc. Amplification method for polynucleotide assays
US5539082A (en) * 1993-04-26 1996-07-23 Nielsen; Peter E. Peptide nucleic acids
DK51092D0 (da) * 1991-05-24 1992-04-15 Ole Buchardt Oligonucleotid-analoge betegnet pna, monomere synthoner og fremgangsmaade til fremstilling deraf samt anvendelser deraf
EP0666923A1 (en) * 1991-09-05 1995-08-16 The University Of Connecticut Targeted delivery of poly- or oligonucleotides to cells

Also Published As

Publication number Publication date
ATE180494T1 (de) 1999-06-15
ES2131612T3 (es) 1999-08-01
DE4331011A1 (de) 1995-03-16
DE59408308D1 (de) 1999-07-01
EP0646596A1 (de) 1995-04-05
SI0646596T1 (en) 1999-08-31
EP0646596B1 (de) 1999-05-26
JPH07112969A (ja) 1995-05-02
US5849893A (en) 1998-12-15
AU7161994A (en) 1995-03-23
GR3030708T3 (en) 1999-11-30
CA2131760A1 (en) 1995-03-14

Similar Documents

Publication Publication Date Title
DK0646595T3 (da) Nukleinsyrer-bindende oligomerer med N-forgrening til terapi og diagnostik
DK0646596T3 (da) Nucleinsyre-bindende oligomerer med C-forgrening til terapi og diagnostik
GR3018541T3 (en) Condensed heterocyclic compounds and their use in therapy.
DK0624595T3 (da) Nor-galdesyrederivater, fremgangsmåde til deres fremstilling og anvendelse af disse forbindelser som lægemidler
ATE280160T1 (de) Substituierte aryl-oder heteroarylamide mit retinoid-ähnlicher biologischer aktivität
ATE141946T1 (de) Hiv-2-virusvarianten
ATE206409T1 (de) N-(1-alkyl-5-phenyl-2,3,4,5-tetrahydro-1-h- benzo(b)(1,5)-diazepin-3-yl)-acetamide
IS4237A (is) Hliðstæð aðferð til framleiðslu ediksýru afleiða og notkunar þeirra sem lyfja
ATE495240T1 (de) Ligand des zelleintritt-vermittelnden proteins von herpes simplex virus und methoden zu dessen verwendung
DK0509398T3 (da) Quinoxaliner, fremgangsmåder til deres fremstilling samt deres anvendelse
ATE248184T1 (de) Dns-sequenzen des humanen cytomegaloviruses
TR199801039T2 (xx) Yeni fenilamidin t�revlerinin elde edilmesine y�nelik usul.
DK0638068T3 (da) Fremgangsmåde til fremstilling af (S)-3-amino-1-substitueret-pyrrolidiner
DK0579968T3 (da) 4-Iminoquinoliner, fremgangsmåde til deres fremstilling og deres anvendelse
NO930205D0 (no) Benzimidazoler, legemidler inneholdende disse, og fremgangsmaate for deres fremstilling
DK446381A (da) Saccharose-mutase immobiliseret saccharose-mutase og anvendelse heraf til fremstilling af isomaltulose (6-0-alfa-d-glucopyranosidod-fructose).
DK1005532T3 (da) Isolerede nukleinsyremolekyler kodende for SSX familiemedlemmer og anvendelser deraf
ES2165358T3 (es) Utilizaciones de la proteinquinasa de neurofilamento/tau pk40.
DK1674575T3 (da) Ligand for Herpes simplex-indgangsmediator og fremgangsmåder til anvendelse
DE69421665T2 (de) Anomere Fluorribosylamine
DE69407533T2 (de) Verwendung von 2,5-substituierten Tetrahydrofuranen als anionische Initiatormodifiziermittel
BR9407232A (pt) Compostos de tiocarbamoíla
ES2068040T3 (es) Sales de 3-(cis-2,6-dimetilpiperidino)-sidnonimina.
ITAQ930006A0 (it) Idrogeli morbidi o semirigidi per uso biomedico.
ITRM920224A1 (it) Sistema ottico per la combinazione di due cammini ottici, in particolare i cammini ottici di uno strumento di diagnostica oculare e di un altro strumento.